Cowin A, McIntosh D, Wormald PJ Healing of wounds created in the nasal mucosa following endoscopic sinus surgery can be affected by different nasal packing materials. Primary Intention Vol. 10 No. 3 August 2002.
Gamoletti R, Lanzarini P, Sanna M, Zini C Regenerated middle ear mucosa after tympanoplasty. Part II. Scanning electron microscopy. Otolaryngol Head Neck Surg. 1986 Apr;94(4):430-4.
Karen A Bednarski, Frederick A. Kuhn, Stents and Drug-Eluting Stents, Otolaryngologic Clinics of North America, Volume 42, Issue 5, October 2009, Pages 857-866, ISSN 0030-6665, http://dx.doi.org/10.1016/j.otc.2009.07.001.(http://www.sciencedirect.com/science/article/pii/S0030666509000930)
Ng M, Linthicum FH Jr Long-term effects of Silastic sheeting in the middle ear. Laryngoscope. 1992 Oct;102(10):1097-102 Cote DWJ, Wright, ED. Objective outcome in endoscopic sinus surgery. In Advances in endoscopic sinus surgery. Prof. Cornel Lancu (Ed.) ISBN:978-953-307-7178
Soper, D S. (2014). A-priori Sample Size Calculator for Student t-Tests [Software]. Available from http://www.danielsoper.com/statcalc
The Effect of Silastic Stenting on Post-Operative Intra-Nasal Re-Mucosalization
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
